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Abstract
Osteoarthritis (OA) is a common joint disease, mainly effecting
the elderly population. The cause of OA seems to be an
imbalance in catabolic and anabolic factors that develops with
age. IL-1 is a catabolic factor known to induce cartilage damage,
and transforming growth factor (TGF)-beta is an anabolic factor
that can counteract many IL-1-induced effects. In old mice, we
observed reduced responsiveness to TGF-beta-induced IL-1
counteraction. We investigated whether expression of TGF-beta
and its signaling molecules altered with age. To mimic the TGF-
beta deprived conditions in aged mice, we assessed the
functional consequence of TGF-beta blocking. We isolated
knee joints of mice aged 5 months or 2 years, half of which were
exposed to IL-1 by intra-articular injection 24 h prior to knee joint
isolation. Immunohistochemistry was performed, staining for
TGF-beta1, -2 or -3, TGF-betaRI or -RII, Smad2, -3, -4, -6 and -
7 and Smad-2P. The percentage of cells staining positive was
determined in tibial cartilage. To mimic the lack of TGF-beta
signaling in old mice, young mice were injected with IL-1 and
after 2 days Ad-LAP (TGF-beta inhibitor) or a control virus were
injected. Proteoglycan (PG) synthesis (35S-sulfate
incorporation) and PG content of the cartilage were determined.
Our experiments revealed that TGF-beta2 and -3 expression
decreased with age, as did the TGF-beta receptors. Although
the number of cells positive for the Smad proteins was not
altered, the number of cells expressing Smad2P strongly
dropped in old mice. IL-1 did not alter the expression patterns.
We mimicked the lack of TGF-beta signaling in old mice by TGF-
beta inhibition with LAP. This resulted in a reduced level of PG
synthesis and aggravation of PG depletion. The limited
response of old mice to TGF-beta induced-IL-1 counteraction is
not due to a diminished level of intracellular signaling molecules
or an upregulation of intracellular inhibitors, but is likely due to
an intrinsic absence of sufficient TGF-beta receptor expression.
Blocking TGF-beta distorted the natural repair response after IL-
1 injection. In conclusion, TGF-beta appears to play an
important role in repair of cartilage and a lack of TGF-beta
responsiveness in old mice might be at the root of OA
development.
Introduction
Osteoarthritis (OA) is a common joint disease characterized
by cartilage damage, osteophyte formation and thickening of
the joint capsule. The etiology of OA is unknown, but OA is
strongly correlated with age. OA may be a result of an age-
related alteration in responsiveness of cells to anabolic and
catabolic stimuli.
IL-1 is a cytokine that plays an important catabolic role in OA.
IL-1 is highly expressed by chondrocytes of joints that are
affected by OA, both in mice and humans [1,2]. Patients with
OA have high levels of IL-1 in their synovial fluids as well [3].
IL-1 itself can induce cartilage damage [4] by reducing prote-
oglycan (PG) synthesis, increasing matrix metalloproteinase
expression [5], and stimulating nitric oxide production [6].
Transforming growth factor (TGF)-beta is an important ana-
bolic factor in OA. It is very beneficial for cartilage as it stimu-
lates PG and collagen type II synthesis and can downregulate
cartilage-degrading enzymes [7-13]. In addition, TGF-beta is
able to counteract IL-1 induced suppression of PG synthesis
[9,14-16]. Through this action TGF-beta is able to protect car-
tilage from damage by IL-1 [9,17,18]. In humans, expression of
IL-1 = interleukin-1; LAP = latency associated peptide; OA = osteoarthritis; PBS = phosphate buffered saline; PG = proteoglycan; TGF-beta = trans-
forming growth factor-beta; TGF-betaR = transforming growth factor-beta receptor.
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an asporin variant with a high TGF-beta inhibitory effect is sig-
nificantly correlated with an increased incidence of OA [19].
Old animals show more prolonged suppression of PG synthe-
sis after IL-1 exposure than young mice [4] and display a
reduced response to counteraction of IL-1 by TGF-beta [20].
This indicates a shift in response to catabolic and anabolic
stimuli, eventually leading to loss of cartilage homeostasis and
OA.
TGF-beta signals predominantly through two receptors, TGF-
beta-RI (ALK5) and TGF-beta-RII. TGF-beta binds to the type
II receptor, recruits and phosphorylates the type I receptor and
subsequently activates its receptor Smad, Smad2 or Smad3,
by phosphorylation [21]. Thereafter, the phosphorylated
Smad2 or Smad3 forms a complex with the common-Smad,
Smad4. The complex is subsequently translocated to the
nucleus where TGF-beta responsive genes are transcribed
[22]. Inside the cell there are also inhibitory Smads (Smad6
and Smad7) that can prevent TGF-beta signaling [23,24].
We postulate that the lack of responsiveness to TGF-beta
counteraction of IL-1 in old mice is due to an overall lack of
responsiveness to TGF-beta caused by a down regulation of
receptors and/or Smad expression or and increase in inhibi-
tory Smads. Therefore, we investigated the expression of the
various TGF-betas (1, 2 and 3) as well as their signaling mol-
ecules (TGF-beta-RI and TGF-beta-RII, Smad2, Smad-2P,
Smad3, Smad4, Smad6 and Smad7) immunohistochemically
in the cartilage of knee joints of young and old mice. In addi-
tion, we assessed whether these expression levels were
altered differently in young and old mice by intra-articular injec-
tion of IL-1α.
We show that old mice have a profoundly lower expression of
TGF-beta receptors (I and II) than young mice, which corre-
lates with less Smad-2 phosphorylation. IL-1 itself had little
effect on the expression of TGF-beta signaling molecules in
cartilage.
To investigate whether reduced TGF-beta response could
cause the reduced repair capacity in old mice, we mimicked
the lack of TGF-beta by blocking TGF-beta activity with
latency associated peptide (LAP) after IL-1 insult. This demon-
strated that endogenous TGF-beta was required for a normal
repair response and that lack thereof aggravates cartilage
damage.
Materials and methods
Animals
Male C57Bl/6 mice aged 5 months or 2 years were used. Ani-
mals were kept in filtertop cages with woodchip bedding
under standard pathogen free conditions. They were fed a
standard diet with tap water ad libitum. The local animal com-
mittee approved this study.
Experimental design
TGF-beta counteraction of IL-1 effects is most likely mediated
by TGF-betaRI, TGF-betaRII and the intercellular Smad pro-
teins. We investigated if young (n = 14) and old (n = 14) mice
differ in expression of these TGF-beta signaling mediators.
Therefore, knee joints were isolated and prepared for immuno-
histochemistry. Half of the joints were prepared for paraffin
sections, half were prepared for frozen sections. The number
of cells staining positive for the various proteins were meas-
ured with a computerized imaging system. In addition to the
comparison between young and old mice, we checked
whether IL-1α injection 24 h prior to knee joint isolation (10
ng) (R&D Systems, Wiesbaden, Germany) influenced the
expression patterns. Thus, the right knee joint of every mouse
was injected with IL-1α and the left knee served as the non-
injected group.
To assess whether lack of TGF-beta could indeed cause
reduced repair capacity in old mice, young mice (n = 14) were
injected intra-articularly with IL-1. Two days later we injected
an adenovirus over-expressing the TGF-beta inhibitor LAP
[25]. This inhibitor scavenges endogenous TGF-beta in the
synovial fluid, preventing it from binding to its receptor. After 4
days, patellae were isolated for measurement of PG synthesis
or whole knee joints were isolated for histology to measure PG
content in the cartilage.
Histology
For the different classes of Smads, knee joints were decalci-
fied for 14 days in EDTA/PVP and subsequently cryosections
of total knee joints (7 µM) were prepared and stored at -20°C.
Before use, sections were air-dried for 30 minutes and freshly
prepared paraformaldehyde (4%, 5 minutes) was used to fix
the sections.
Immunohistochemistry for TGF-beta1, TGF-beta2, TGF-
beta3, TGF-betaRI, TGF-betaRII and Smad-2P, as well as
Safranin O/Fast Green staining, were performed on paraffin
sections from total knee joints. Knee joints were fixed in phos-
phate buffered formalin for 7 days. They were dehydrated
using an automated tissue-processing apparatus (Tissue Tek
VIP, Sakura, Ramsey, MN, USA) and embedded in paraffin.
Tissue sections of 7 µM were prepared.
Immunohistochemistry
Sections were deparaffinized and washed with PBS. For anti-
gen unmasking, sections were incubated in citrate buffer (0.1
M sodiumcitrate, 0.1 M citric acid) for 2 h. Endogenous perox-
idase was blocked with 1% hydrogen peroxidase in methanol
for 30 minutes. Thereafter, sections were blocked with 5%
normal serum of the species in which the secondary antibody
was produced. Specific primary antibodies against TGF-
beta1, TGF-beta2, and TGF-beta3 (1.0 µg/ml), TGF-betaRI
and TGF-betaRII, Smad2, Smad3 and Smad4 (0.5 µg/ml),
Smad6 (1.0 µg/ml), Smad7 (3.3 µg/ml) and Smad-2P (1:100)
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were incubated overnight at 4°C. (Smad6 antibody was pur-
chased from Invitrogen (Breda, The Netherlands), Smad-2P
from Cell Signaling Technology (Beverly, MA, USA), and all
other primary antibodies were purchased from Santa Cruz
Biotechnology Inc (Santa Cruz, CA, USA)). As a negative con-
trol, the primary antibody was replaced with goat or rabbit
IgGs. After extensive washing in PBS, the appropriate biotin
labeled secondary antibody was used at a concentration of 2
µg/ml in 1% bovine serum albumin/PBS for 2 h (Vector Labo-
ratories Inc, Burlingame, CA, USA), followed by a biotin-
streptavidine detection system according to the manufac-
turer's protocol (Vector Laboratories Inc.). Bound complexes
were visualized via reaction with 3',3'-diaminobenzidine
(Sigma Chemicals Co, Zwijndrecht, The Netherlands) and
H2O2 resulting in a brown precipitate. Sections were briefly
counterstained with hematoxylin and mounted with Permount.
Image analysis: quantification of positively stained 
articular chondrocytes
For the different antigens, the number of positive articular
chondrocytes in the tibia was determined by a blinded
observer. The microscopic image was displayed on a compu-
ter monitor using the Qwin image analysis system (Leica Imag-
ing Systems, Rijswijk, The Netherlands) and a Leica DC 300F
digital camera. The area representing the non-calcified articu-
lar cartilage was selected by hand. For each antigen, a thresh-
old was set in such a manner that only chondrocytes that were
found to be positive (brown stained cell) as judged by the
observer were selected. The computer program determined
the number of positive cells in the cartilage for the different
antigens. For each knee joint, the expression of the different
antigens was measured in at least three tissue sections. The
intensity of the staining was not taken into account as no obvi-
ous differences were observed in staining intensities in the dif-
ferent experimental groups: young/old or -IL-1/+IL-1. The
obtained values were averaged and the average per treatment
group was determined. To correct for differences in cell
number between young and old mice, the average number of
chondrocytes in the non-calcified cartilage was determined in
sections stained with hematoxylin only for both paraffin and
frozen sections. This was based on a similar selection proce-
dure to that described above with the exception that selection
of chondrocytes was based on the blue staining from heama-
toxylin instead of brown staining. The average number of
chondrocytes per sections was calculated for every joint.
Image analysis: proteoglycan content
PG content of articular cartilage was measured in sections
stained with Safranin O and Fast Green using a computerized
imaging system as previously described [25]. Briefly, Safranin
O stains PGs in the cartilage red. A blinded observer captured
an image on screen and selected the cartilage. The computer
then measured the amount of blue light passing through the
selected area. The higher the amount of light passing through,
the lower the amount of PGs in cartilage. The average of three
sections per knee joint was calculated.
Proteoglycan synthesis
PG synthesis was assessed by measurement of 35S-sulfate
incorporation. Isolated patellae were immediately placed in
Dulbecco's modified Eagle's medium with gentamicin (50 mg/
ml) and pyruvate. After half an hour, this medium was replaced
by medium containing 35S-sulfate 20 µCi/ml in which patellae
were incubated for 3 h at 37°C and 5% CO2. Thereafter, patel-
lae were further prepared for determining the amount of 35S-
sulfate incorporation in the articular cartilage as previously
described [22].
Statistical analysis
Results were analyzed with the Student's t-test and consid-
ered significant if the p-value was smaller than 0.05.
Results
Chondrocyte cell number is reduced with age
The percentage of cells expressing the different TGF-beta sig-
naling proteins in murine cartilage was calculated by correc-
tion for the total number of cells present in the articular
cartilage of the tibia. Therefore, the total number of cells in
both medial and lateral tibial cartilage was quantified for all
experimental groups by computerized quantification of cell
number in hematoxyline and eosin (H&E) stained sections. Old
mice had a significantly lower number of chondrocytes in the
tibial cartilage: the reduction was more pronounced in the
medial tibial cartilage, with a reduction in cell number of 34%;
the number of cells in lateral tibial cartilage had reduced 17%.
(Fig. 1). Treatment with IL-1 had no effect on the total number
of cells (data not shown).
Figure 1
Number of cells in medial and lateral tibial cartilage of 5 month and 2 year old C57Bl/6 mice
year old C57Bl/6 mice. Paraffin sections of knee joints of young (5 
months old) and old (2 years old) mice were stained with hematoxylin 
and eosin after which a blinded observer used a computerized imaging 
system to count the number of chondrocytes in the tibial cartilage. Old 
mice have a lower number of cells in their cartilage than young mice. 
The reduction in cell number is more pronounced on the medial side of 
the joint. Error bars display the standard error. For statistical analysis, a 
Student's t-test was used. * = p < 0.05; ** = p < 0.005; *** = p < 
0.0005.
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Reduction of various TGF-beta signaling molecules with 
age
To assess whether the reduced TGF-beta responsiveness in
old mice was due to a lower amount of TGF-beta expression
we compared the number of TGF-beta positive cells in the tib-
ial cartilage of young (5 months old) and old mice (2 years old)
in immunohistochemically stained sections. The number of
positive cells was quantified with a computerized imaging sys-
tem and corrected for the total amount of chondrocytes. In
both medial and lateral tibial cartilage, age had no effect on the
number of TGF-beta1 expressing cells. However, the number
of cells expressing TGF-beta2 in old mice had reduced from
30% to almost no positive cells left (average of 0.2%) on the
medial side of the joint and from 32% to 2% on the lateral tibial
cartilage (Fig. 2f, h). TGF-beta3 showed a similar pattern in
medial tibial cartilage, where the number of positive cells was
31% in young mice compared to 1% in old mice. On the lateral
side of the joint, ageing also resulted in a lower number of
TGF-beta3 positive cells, but this was not significant (Fig. 3).
We also examined the effect of aging on the number of cells
staining positive for the TGF-betaRs. TGF-betaRI was
expressed by a significantly lower number of cells in the medial
tibial cartilage in old mice compared to young mice, 2% com-
pared to 21%, respectively. On the lateral side, the number of
TGF-betaRI positive cells was also lower in old mice, but this
was not significant. The amount of cells expressing TGF-
betaRII was significantly lower in old mice, both on the medial
and on the lateral side of the joint. On the medial side, the
number of immunopositive cells was reduced with age from
27% in young mice to 4% in old mice; in the lateral tibial car-
tilage the reduction was from 26% to 6% (Figs 4 and 2e, g).
In contrast to the receptors, the number of cells positive for the
several Smad molecules had hardly changed with age. The
percentage of cells positive for receptor-Smad Smad2 was
equal in young and old mice (Fig. 2a, c). The expression of
receptor-Smad Smad3 had increased in old mice as well as
the percentage of cells positive for the common-Smad,
Figure 2
Staining of various transforming growth factor (TGF)-beta signaling molecules in cartilage
molecules in cartilage. Paraffin sections of knee joints of young and old 
mice were stained with antibodies against (a,c) Smad2, (b,d) Smad-
2P, (e,g) TGF-beta receptor II (TGF-betaRII) and (f,h) TGF-beta2. The 
medial tibia of the young mice clearly show a high number of cells stain-
ing positive for (b) Smad-2P, (e) TGF-betaRII and (f) TGF-beta2, 
whereas the (d,g,h) old mice had only a very low number of cells stain-
ing positive for these factors. (a,c) Smad2 staining remained 
unchanged with age. F, femur; T, tibia.
Figure 3
Percentage of cells expressing transforming growth factor (TGF)-beta in medial and lat ral tibial cartilage
in medial and lateral tibial cartilage. Paraffin sections of knee joints of 
young (5 months old) and old (2 years old) mice were stained immuno-
histochemically with antibodies against TGF-beta1, TGF-beta2 or TGF-
beta3. Subsequently, the number of cells staining positive in the carti-
lage were scored with a computerized imaging system and corrected 
for the total number of cells. (a) In medial cartilage, TGF-beta2 and 
TGF-beta3 expression were significantly reduced with age. (b) In lateral 
cartilage, TGF-beta2 was significantly reduced. Error bars display the 
standard error. For statistical analysis, a Student's t-test was used. * = 
p < 0.05.
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Smad4, but only in the medial tibial cartilage. The inhibitory
Smad, Smad6, was not altered with age in the medial tibial
cartilage, but was higher in old mice on the lateral side. Smad
7 was significantly higher in old mice, but this was limited to
the medial tibial cartilage (Fig. 5).
Despite the lack of difference in Smad2 expression between
young and old mice, the phosphorylated variant of this Smad,
Smad-2P, was significantly reduced in old mice in both medial
and tibial cartilage. In the medial tibial cartilage, the percent-
age of cells staining positive for Smad-2P was 53% in young
mice compared to 5% in old mice. On the lateral side, aging
had lowered the amount of immunopositive cells from 85% to
30% (Figs 6 and 2b, d). This indicates a decrease in active
TGF-beta signaling in old mice, possibly related to the
decreased number of TGF-betaRs in old mice.
To assess whether IL-1 itself altered TGF-beta signaling in old
mice, thereby reducing the counteractive abilities of TGF-beta
to IL-1, we examined the effect of IL-1 injection on the expres-
sion of TGF-beta signaling components in the articular carti-
lage. Injection of IL-1 24 h prior to knee joint isolation resulted
in an increased expression of TGF-beta1 and TGF-beta2 in lat-
eral tibial cartilage in old mice and a higher number of Smad2
positive cells in the medial tibial cartilage. IL-1 treatment did
not influence TGF-beta receptor, Smad or Smad2P expres-
sion in old mice (Fig. 7). IL-1 did not alter the expression of the
TGF-beta signaling components in young mice.
Effect of blocking TGF-beta on proteoglycan synthesis 
and proteoglycan content
To assess the functional consequence of depressed TGF-
beta signaling, we blocked TGF-beta by adenoviral overex-
pression of the TGF-beta inhibitor LAP two days after IL-1
insult. Four days after primary insult, knee joints were isolated
for assessment of PG synthesis and PG content. PG synthe-
sis was measured by 35S-sulfate incorporation into cartilage ex
vivo. A normal response to IL-1 insult is an initial drop in PG
synthesis the first 2 days after IL-1 injection, followed by a
rapid increase in synthesis within the next 2 days [4]. The
increased synthesis levels are above normal turnover levels.
LAP over-expression after IL-1 injection was able to com-
pletely block this intrinsic increase in PG synthesis as shown
by the 35S-sulfate incorporation, which was lower than after IL-
1 insult alone (Fig. 8a).
In addition, PG content was measured by quantification of
Safranin O staining intensity of the cartilage. The block of
endogenous TGF-beta resulted in an aggravation of cartilage
damage as the PG content of the cartilage was significantly
reduced beyond IL-1 induced PG depletion (Fig. 8b). These
data show that deprivation of TGF-beta resulted in a reduced
repair capacity of the cartilage.
Discussion
OA is characterized by cartilage damage with an increasing
incidence with age. The etiology of OA is unknown, but an
imbalance between catabolic and anabolic factors appears to
be involved. Whereas chondrocytes of young mice respond
well to TGF-beta counteraction of IL-1, those of old mice show
less efficient counteracting of IL-1 by TGF-beta [20]. In addi-
tion, they display prolonged suppression of PG synthesis. This
might be due to a decreased response to TGF-beta in carti-
lage of old mice. We compared, therefore, the expression of
TGF-beta and the TGF-beta signaling components in cartilage
of young and old mice. The cartilage of old mice contained a
lower number of cells than young mice. We thus corrected our
findings for the total number of cells in the examined cartilage.
In this study, only the tibial cartilage is discussed, but similar
changes occurred in the femoral cartilage. The reduced cell
number we found in old mice corresponds to the decreased
number of cells that was found in cartilage of human donors
older than 40 [26]. A decrease in chondrocyte cell number
could be due to an age-related decline in (TGF-beta-induced)
chondrocyte proliferation rate [27,28].
Our results show that old mice have significantly lower num-
bers of cells expressing TGF-beta2 and TGF-beta3 than
young mice. In addition, old animals had a significantly lower
number of chondrocytes expressing TGF-betaRs. The lack of
Figure 4
Percentage of cells expressing transforming growth factor (TGF)-beta receptors (TGF-betaRs)
receptors (TGF-betaRs). Paraffin sections of knee joints of young (5 
months old) and old mice (2 years old) were stained immunohistochem-
ically with antibodies against TGF-betaRI or TGF-betaRII. Subse-
quently, the number of cells staining positive in the cartilage were 
scored with a computerized imaging system and corrected for the total 
number of cells. The expression of both receptors was reduced with 
age in both (a) medial and (b) lateral tibial cartilage, but the reduced 
TGF-betaRII was significant only in lateral tibial cartilage. Error bars dis-
play the standard error. For statistical analysis, a Student's t-test was 
used. * = p < 0.05; ** = p < 0.005; *** = p < 0.0005.
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responsiveness to TGF-beta counteraction in old mice is not
likely a result of alterations in Smad expression, as they are
unaffected or even elevated by aging. Smad3 was elevated in
tibial cartilage, and in the medial tibial cartilage we found an
elevation of Smad4 with age. The basal material for signaling
inside the cell is present, only the action is lacking. This lack of
action might be due to the reduced receptor expression com-
bined with a drop in TGF-beta2 and TGF-beta3 in old mice.
This could also explain the lower Smad2 phosphorylation in
old mice. Smad2 itself is not a problem as it is present in equal
numbers in both young and old mice, but if there are less
receptors and less ligands, Smads are unlikely to be phospho-
rylated in high amounts.
In lateral tibial cartilage we found an elevation of Smad6
expression with age, while in medial tibial cartilage Smad7
was elevated with age; these changes were restricted to one
cartilage surface only instead of both. Although it might
contribute, it is unlikely that this elevation is the cause of the
overall unresponsiveness to TGF-beta.
Figure 5
Percentage of cells expressing Smad in medial and lateral tibial cartilage. Frozen sections of knee joints of young (5 months old) and old (2 years 
old) mice were stained immunohistochemically with antibodies against Smad2, Smad3, Smad4, Smad6 or Smad7. Subsequently, the number of 
cells staining positive were scored with a computerized imaging system and corrected for the total number of cells. (a) In medial tibial cartilage, 
expression of Smad3, Smad4 and Smad7 increased with age. (b) In lateral tibial cartilage Smad3 and Smad6 expression increased with age. Error 
bars display the standard error. For statistical analysis, a Student's t-test was used. * = p < 0.05; *** = p < 0.0005.
Figure 6
Percentage of cells expressing Smad-2P in medial and lateral tibial cartilage car-
tilage. Paraffin sections of knee joints of young (5 months old) and old 
(2 years old) mice were stained immunohistochemically with antibodies 
against Smad-2P. Subsequently, the number of cells staining positive 
were scored with a computerized imaging system and corrected for the 
total number of cells. The Smad-2P expression was reduced with age in 
both medial and lateral tibial cartilage. Error bars display the standard 
error. For statistical analysis, a Student's t-test was used. *** = p < 
0.0005.
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We wanted to make sure that IL-1 itself did not alter TGF-beta
signaling and cause the reduced counteraction. Therefore,
mice were exposed to IL-1 prior to knee joint isolation. IL-1
treatment had only little effect on TGF-beta signaling. In old
mice, we found an upregulation of TGF-beta1 and TGF-beta2
in lateral tibial cartilage. In the medial tibial cartilage, we
observed an IL-1-induced increase in Smad2. Although there
was elevation of these factors, it had no effect on Smad-2P,
indicating that IL-1 treatment did not alter the outcome of TGF-
beta signaling.
Iqbal et al. [29] found a decrease in the expression of mRNA
for TGF-beta1, TGF-beta2 and TGF-beta3 with age in equine
cartilage, supporting our findings. It is not clear why the TGF-
beta isoforms show a different pattern but it is known that all
three isoforms are differentially regulated and have a different
promotor region. Also, during embryogenis all three isoforms
show a different, developmental stage related expression pat-
tern [30]. Gómez-Camarillo et al. [31] also showed a progres-
sive decrease of TGF-betaRI with age. Matsunaga et al. [32]
found similar expression patterns in cervical intervertebral
discs in mice. They showed a decrease in expression of TGF-
beta1, TGF-beta2 and TGF-beta3 as well as TGF-betaRI and
TGF-betaRII with age. In myogenic progenitor cells in mice,
Beggs et al. [33] described similar observations. They found
that TGF-betaRI and TGF-betaRII were downregulated and
Smad2, Smad3, Smad4 and Smad7 remained unchanged
[33]. These data indicate that our findings are similar to those
found in other species and cell types and that the phenome-
non of reduced TGF-betaRs and reduced TGF-beta expres-
sion it is not limited to cartilage of murine knee joints.
IL-1 treatment increased the expression of TGF-beta1 and
TGF-beta2 in tibial cartilage. Andriamanalijaona et al. [34]
Figure 7
Effect of IL-1 on expression of TGF-beta signaling proteins in cartilage. Knee joints of (a) young (5 months old) and (b) old (2 years old) mice were 
injected with IL-1 24 h prior to isolation of the knee joints. Paraffin sections of knee joints were stained immunohistochemically for TGF-beta1, TGF-
beta2, TGF-beta3, TGF-beta receptor I (TGF-betaRI), TGF-betaRII, Smad2, Smad3, Smad4, Smad6, Smad7 and Smad-2P. Subsequently, the 
number of cells staining positive were scored with a computerized imaging system and corrected for the total number of cells. After IL-1 injection, 
Smad2 expression increased only in the medial tibial cartilage and TGF-beta1 and TGF-beta2 expression increased only in the lateral tibial cartilage. 
Error bars display the standard error. For statistical analysis, a Student's t-test was used. * = p < 0.05.
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have also shown the ability of IL-1 to increase TGF-beta1 of
articular chondrocytes. Kaiser et al. [35] showed that IL-1
treatment resulted in elevated expression of Smad7 mRNA in
vitro after 3 days. In our in vivo experiment, however, no signif-
icant alterations in inhibitory Smad expression were found. In
contrast to Kaiser et al. [35], we measured the percentage of
cells expressing Smad7 one day after IL-1 injection in vivo.
The discrepancies in time, measurement and system probably
explain why different results were found.
We previously examined TGF-beta expression in OA. In severe
OA in STR/ort mice, we did not find any TGF-beta expression
or Smad-2P at all, whereas younger STR/ort mice with only
mild damage still expressed both factors (data not shown). In
addition, others have also found discrepancies between OA
cartilage and healthy cartilage with respect to TGF-beta
expression. Gomez-Camarillo and Kouri [31] showed that
TGF-beta1 receptors were very scarce in experimental OA.
The drop in expression levels of TGF-beta and their signaling
molecules that we found in old mice might precede OA.
The expression patterns in the cartilage suggest that a lack of
TGF-beta signaling plays a potential role in the reduced repair
capacity in old mice and possibly in OA. To further investigate
whether the disturbed TGF-beta signaling could cause a
reduction in repair, we inhibited endogenous TGF-beta after
IL-1 insult. This resulted in a total block of the increased PG
synthesis, thereby reducing the intrinsic repair capacity of the
cartilage. The reduced PG synthesis resulted in an aggrava-
tion of the IL-1-induced PG loss in cartilage. These results
show that not only do old mice have a reduced TGF-beta
signaling capacity, but also that disrupted TGF-beta signaling
can indeed induce a distorted repair capacity of cartilage.
It has been hypothesized that TGF-beta treatment can be used
as a factor for cartilage repair. However, old mice respond
poorly to TGF-beta, so the use of TGF-beta for repair might be
more difficult than expected. It has already been shown that
human articular chondrocytes stimulated with TGF-beta1,
fibroblast growth factor-2 and platelet derived growth factor-
BB, contained more glycosaminoglycans than non-stimulated
controls, but only if donors were younger than 40 [26]. In addi-
tion, stimulation of equine articular cartilage with TGF-beta
resulted in lower [35S]Na2SO4 incorporation in horses of 20
years old compared to 9 month old horses [26,29]. Although
the response to TGF-beta is reduced with age, it does not
mean that the cartilage does not respond at all. There was still
an increase in incorporation of [35S]Na2SO4 after TGF-beta
stimulation found by Livne et al. [36] in mice, but it has to be
considered that this response in old animals cannot be com-
pared to the massive stimulation in young animals. However,
finding ways to stimulate cartilage repair bypassing the TGF-
beta receptor pathway appears to be an attractive option to
boost repair of aged cartilage.
Conclusion
Our data show that there are less chondrocytes expressing
TGF-betaRs in cartilage in old mice. Smad expression is
unchanged, but Smad2 phosphorylation is reduced with age.
These data suggest that the reduced TGF-beta counteraction
of IL-1 induced cartilage damage of old mice is due to an
overall lack in TGF-beta signaling capacity. Blocking endog-
enous TGF-beta in young mice induced a distorted repair
capacity in cartilage. The reduced ability of chondrocytes to
respond to anabolic factors during aging might play a role in
the development of the age-related disease OA.
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